INTEGRATIVE MEDICINE CASE REPORTS VOLUME 3 NUMBER 2 JULY 2022 www.jimcr.com IMCR RES ARTICLE 42 Efcacy of AYUSH Common Yoga protocol along with Surya Namaskar on the Dyslipidemia subjects in Haryana Jaideep Arya 1 *, Divya Singh 2 , Harshit Manav 3 , Kalyan Maity 4,5 , Yashvi Bhat 6 , Rohin Vinayak 7 , Saras Jyoti 1 , Shweta Ahuja 8 , Monika Gautam 9 , Navneet Kaur 10 , Jyoti Arya 11 and Gurmeet Singh 12 1 Haryana Yog Aayog, AYUSH Department, Panchkula, Haryana, India 2 Center of Integrative Medicine and Research (CIMR), All India Institute of Medical Sciences (AIIMS), New Delhi, India 3 Lal Bahadur Shastri National Academy of Administration, (Govt. of India), Mussoorie, Uttarakhand, India 4 Division of Yoga and Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana (S-VYASA), Bengaluru, Karnataka, India 5 Neuroscience Research Lab, Department of Neurology, Post Graduate Institute of Medical Education & Research, Chandigarh, India 6 Indian Institute of Science Education and Research (IISER), Mohali, Punjab, India 7 Dayanand Medical College & Hospital, Ludhiana, Punjab, India 8 Trinity Hospital and Medical Research Institute, Mohali, Punjab, India 9 Collaborative Centre for Mind Body Interventions through Yoga, PGIMER, Chandigarh, India 10 Government Model Sanskrit Senior Secondary School, Morni Hills, Panchkula, Haryana, India 11 Patanjali Ayurvedic College, UAU Uttarakhand, India 12 Department of Physical Education, Panjab University, Chandigarh, India ABSTRACT Background: Dyslipidemia might be the cause of many cardiovascular diseases (CVD). Yoga intervention is known to prevent the progression of various lifestyle-based health conditions. Dyslipidemia marks the onset of early CVD, and a Yoga based-intervention at this stage might reverse the progression. Aim: To analyze the efect of AYUSH Common Yoga Protocol (CYP) and CYP combined with Surya Namaskar (CYP-SN) on dyslipidemia subjects in Haryana. Method: A three-arm randomized controlled trial was carried out in which ninety individuals were allocated into three groups, CYP group, CYP-SN group and control group. Result: The three-month intervention resulted in elevation of HDL- cholesterol (HDL-C) levels in the group that had undergone CYP protocol, as well as CYP-SN protocol, implying the benefts of Surya Namaskar in modifying lipid profle refecting an improvement in the dyslipidemia. Conclusion: CYP and CYP-SN Yoga group when practiced regularly for a sustained period can help in reducing co-morbidity and severe CVD in subjects with dyslipidemia. When implemented in dynamic way, CYP-SN has shown to have a greater impact in management of dyslipidemia. doi: 10.38205/imcr.030242 KEY WORDS CVD Dyslipidemia HDL-C Surya Namaskar Yoga Common Yoga Protocol *Corresponding Author: Jaideep Arya, Chairman Haryana Yog Aayog, AYUSH Department, Panchkula, Haryana, India Contact no: +91-9760095100 E-mail: jaiarya1973@gmail.com Introduction Dyslipidemia is a modifiable risk factor for cardiovascular disease associated mortality and morbidity (1). Patients with cardiovascular disease (CVD) have disturbed level of LDL cholesterol (LDL-C), elevated triglycerides, and reduced HDL cholesterol (HDL-C) levels in the blood. The combination of elevated triglycerides and reduced HDL-C is of paramount importance in detecting the onset of an underlying disorder of glucose homeostasis, insulin resistance (IR), or Diabetes Mellitus (DM2). Numerous studies have shown a relationship between lifestyle-related disorders such as dyslipidemia, dia- betes, and hypertension (1–3). Dyslipidemia is related to the increased risk for accumulation of diabetes and hypertension (2,3). Concisely, dyslipidemia, diabetes, hypertension, and obe- sity contributed to the elevation of CVD (4). This is observed that more than 50% adult population has dyslipidemia across the world (2–4). An epidemiological study in India reported that 25–30% of urban and 15–20% of the rural population have elevated levels of cholesterol (5). Dyslipidemia is an alteration in the lipoprotein metabolism that encompasses lipoprotein overproduction/deficiency. It is also reported that patients who has background of ischemic stroke, Transient ischemic attack (TIA) and atherosclerosis having LDL-C level of less than 70 mg/dL possess less risk of subsequent stroke and other CVD than those who had LDL cholesterol of 90 mg/ dL to 110 mg/dL (6). Recent findings show that pharmacolog- ical drugs like Ezetimibe or Proprotein convertase subtilisin– Kexin type 9 inhibitors plus statins can be beneficial in stroke reduction owing to their triglyceride lowering properties (7). Regardless of medications, patients are advised to adopt a healthy lifestyle and regular exercise for CVD risk reduction. After considering comorbidities, statin therapy is recom- mended for further prevention (6). In India, the estimated economic burden of heart disease on non-medical spending per person amounts to INT$110.64 (INT-international dollar) annually, hence suggesting dyslipidemia as a factor contrib- uting to the financial burden (8). In addition to this, various